1. Home
  2. TWIN vs CHRS Comparison

TWIN vs CHRS Comparison

Compare TWIN & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

N/A

Current Price

$24.16

Market Cap

367.7M

Sector

Industrials

ML Signal

N/A

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

N/A

Current Price

$0.64

Market Cap

159.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWIN
CHRS
Founded
1918
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
159.1M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
TWIN
CHRS
Price
$24.16
$0.64
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $7.75
AVG Volume (30 Days)
55.3K
★ 1.6M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
★ 0.81%
N/A
EPS Growth
★ 1428.57
472.00
EPS
★ 0.24
N/A
Revenue
★ $381,270,000.00
N/A
Revenue This Year
$7.56
$34.69
Revenue Next Year
$8.00
$70.40
P/E Ratio
$103.33
★ N/A
Revenue Growth
★ 11.90
N/A
52 Week Low
$14.22
$0.73
52 Week High
$29.24
$2.62

Technical Indicators

Market Signals
Indicator
TWIN
CHRS
Relative Strength Index (RSI) 46.70 32.51
Support Level $22.34 N/A
Resistance Level $24.52 $1.53
Average True Range (ATR) 1.45 0.10
MACD -0.09 -0.02
Stochastic Oscillator 36.15 6.37

Price Performance

Historical Comparison
TWIN
CHRS

About TWIN Twin Disc Incorporated

Twin Disc Inc designs, manufactures and sells marine and heavy-duty off highway power transmission equipment. Its products are marine transmissions, azimuth drives, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, controls systems, and braking systems. The company sells its products to customers in the pleasure craft, commercial, and military marine markets, as well as in the energy and natural resources, government, military, and industrial markets. It has two reportable segments: manufacturing and distribution. It derives the maximum revenue from the manufacturing segment. Geographically, it operates in United States, Netherlands, Finland, China, Australia, Italy and Others.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Share on Social Networks: